When does the nepafenac patent expire in Germany?
I don’t have the specific patent/PA number or the relevant German filing(s) needed to determine the exact expiry date for nepafenac in Germany from the information provided. Patent expiry dates depend on the specific granted patent(s) and the last validated extensions in each country, which can differ from the US/EU timelines.
If you share either (a) the specific product name marketed in Germany (and strength), or (b) the patent/EP number you mean, I can map it to the Germany expiry/last-in-force date more precisely.
What should you check for nepafenac exclusivity in Germany (patents vs. extensions)?
In Germany (and the wider EU), market exclusivity commonly depends on more than one layer, not just the “main” patent:
- the last expiring granted patent claim for the specific medicinal product/presentation in Germany, and
- any legally recognized extensions/adjustments tied to that patent in Germany (often linked to regulatory approval timing), and
- whether additional exclusivity mechanisms (like supplementary protection) are relevant for the product’s regulatory dossier.
Without the exact patent identifiers, it’s not possible to state a single “the” expiry date for Germany.
Does “nepafenac” refer to the same drug as in the EU ophthalmic listings?
“Nepafenac” is used for ophthalmic indications (commonly in eye drops). Patent coverage can be tied to:
- the active ingredient,
- specific formulations/dosages,
- specific medical uses/indications,
- and even manufacturing/process claims.
Your Germany expiry date can change if you mean exclusivity for one specific indication or formulation rather than the general active ingredient.
Can generic nepafenac enter Germany immediately after patent expiry?
Even if a patent expires, generics in Germany can still be delayed by:
- earlier “second” or “later” expiring patents covering specific aspects (formulation/use),
- regulatory requirements for approval and market authorization,
- and any litigation affecting effective launch timing (for example, injunctions linked to patent challenges).
So the commercial “launch date” can be later than the last patent expiry date unless you identify exactly which patent(s) control.
If you want, I can give the exact Germany expiry—what to provide
Reply with one of the following, and I’ll translate it into the Germany patent expiry/exclusivity date you’re looking for:
1) The German product brand name (and strength) that you mean, or
2) The patent number(s) (e.g., EP/DE publication number) you’ve seen referenced, or
3) The EU/EP patent number and the nepafenac formulation/indication you care about.
Sources
None cited (the provided prompt did not include patent numbers, product names, or any reference documents to cite).